The Visuo-Motor Attention Test in Boys with Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate—Placebo Randomized Controlled Trial

被引：0
作者：
Yaffa Hadar
Shraga Hocherman
Oren Lamm
Emanuel Tirosh
机构：
[1] Haifa University,Department of Special Education, Faculty of Education
[2] Israel Institute of Technology,The Rappaport Family Faculty of Medicine
[3] The Hannah Khoushy Child Development Center,undefined
[4] Bnei Zion Medical Center,undefined
来源：
Child Psychiatry & Human Development | 2021年 / 52卷
关键词：
ADHD; Methylphenidate; Placebo; ADHD subtype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To assess the visuomotor attention ability in children with ADHD and controls and their response to placebo and Methylphenidate (MPH) treatment. 36 boys with ADHD and 36 age matched typical controls were administered the visuomotor attention test (VMAT) as a baseline and following a week of MPH(IR) or placebo administered to the study group, in a randomized crossover design. A significant difference between the study and control groups was found on several VMAT measures. No performance difference between ADHD dimensional sub-types was observed at the baseline assessment. Under MPH treatment a significant improvement in VMAT measures was observed and particularly in the combined and predominantly hyperactive (C\HI) type. The VMAT results obtained in the present study are consistent with previous findings. ADHD subtypes appear similarly short of visuomotor attention resources; a visuomotor test can be used in the assessment of gains derived from MPH treatment
引用
收藏
页码：96 / 103
页数：7
相关论文
共 184 条
  • [11] Mulder T(2011)ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/ hyperactivity disorder in children and adolescents Pediatrics 128 1007-1022
  • [12] Langmaid RA(2012)Motor skills of children newly diagnosed with attention deficit hyperactivity disorder prior to and following treatment with stimulant medication Res Dev Disabil 33 2080-2087
  • [13] Papadopoulous N(2004)Response selection and execution in patients with Parkinson's disease Brain Res Cogn Brain Res 19 40-51
  • [14] Johnson BP(2006)Visuomotor tracking related to attention-deficit hyperactivity disorder (ADHD) J Child Neurol 21 503-507
  • [15] Phillips J(1993)Predictive value of placebo methylphenidate J Pediatr Neurol 99 131-133
  • [16] Rinehart NJ(2012)Gender differences among children with ADHD on continuous performance tests: a meta-analytic review J Atten Disord 16 190-198
  • [17] Pitcher TM(2010)Neuropsychological profile of executive function in girls with attention-deficit/hyperactivity disorder Arch Clin Neuropsychol 25 656-670
  • [18] Piek JP(2007)Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate J Am Acad Child Adolesc Psychiatry 46 701-710
  • [19] Barrett NC(2015)Gender differences in the behavioral symptoms and neuropsychological performance of patients with attention-deficit/hyperactivity disorder treated with methylphenidate: a two-year follow-up study J Child Adolesc Psychopharmacol 25 501-508
  • [20] Kaiser ML(2001)Comorbidity among individuals classified with attention disorders Int J Neurosci 110 43-54
12345678910